HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
CYTK
Cytokinetics Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $9.95B
Market Cap
$9.95B
Enterprise Val
$10.42B
P/E Ratio
-12.00
P/B Ratio
-12.04
Trailing PEG (1Y)
-0.53
As Of
Jun 24, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value-$826.6M
Gross Margin86.81%
Profit Margin86.81%
Return on Equity139.66%
Return on Assets-61.91%
Current Ratio4.21
Debt/Equity-1.56
LT Debt/Equity-1.48
Revenue Per Share0.16

Income Statement

Mar 31, 2026
Revenue$19.4M
Cost of Revenue$2.6M
Gross Profit$16.8M
R&D$95.5M
SG&A$104.9M
Operating Expenses$200.4M
Operating Income-$183.6M
Interest Expense$14.5M
Tax Expense$0.00
Net Income-$206.0M
EPS (Basic)$-1.67
EPS (Diluted)$-1.67
EBIT-$191.5M
EBITDA-$188.1M
Consolidated Income-$206.0M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$129.8M
Accounts Receivable$6.8M
Inventory$4.0M
Current Assets$839.5M
LT Investments$254.7M
Property, Plant & Equipment$157.0M
Intangibles$0.00
Non-Current Assets$434.0M
Total Assets$1.27B
Accounts Payable$24.7M
Current Debt$65.8M
Current Liabilities$199.2M
LT Debt$1.22B
Non-Current Liabilities$1.90B
Total Liabilities$2.10B
Total Debt$1.29B
Retained Earnings-$3.69B
Shareholder Equity-$826.6M
Shares Outstanding123,162,807

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow-$145.5M
Investing Cash Flow$145.5M
Financing Cash Flow$7.8M
CapEx-$5.9M
Free Cash Flow-$151.4M
Depreciation & Amort.$3.4M
Stock-Based Comp$30.4M
Acquisitions / Disposals$0.00
Investment Activity$151.4M
Debt Issued/Repaid-$2.7M
Equity Issued/Repaid$11.3M
Dividends Paid$0.00
Net Change in Cash$7.3M
Data cached · Meta live · Daily live · Statements live · TTL 24h